Literature DB >> 22459739

Estimating the variability in the risk of infection for hepatitis C in the Glasgow injecting drug user population.

A J Sutton1, S A McDonald, N Palmateer, A Taylor, S J Hutchinson.   

Abstract

Glasgow (Scotland's largest city) has a high prevalence of injecting drug use and has one of the highest prevalences of hepatitis C virus (HCV) infection in injecting drug users (IDUs) in Western Europe. HCV prevalence data from surveys of Glasgow's IDUs from 1990 to 2007 were utilized and a model was applied that described the prevalence of HCV as a function of the rate (force) of infection. Force-of-infection estimates for HCV that may vary over time and injecting career length over a range of variables were investigated. New initiates to injecting were found to be at increased risk of HCV infection, with being recruited from a street location and reporting injecting in prison leading to a significant increase in the risk of infection in new initiates. These results indicate areas of importance for the planning of public health measures that target the IDU population.

Entities:  

Mesh:

Year:  2012        PMID: 22459739      PMCID: PMC9152331          DOI: 10.1017/S0950268812000489

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  21 in total

1.  Extent and contributing factors of drug expenditure of injectors in Glasgow. Multi-site city-wide cross-sectional study.

Authors:  S J Hutchinson; S M Gore; A Taylor; D J Goldberg; M Frischer
Journal:  Br J Psychiatry       Date:  2000-02       Impact factor: 9.319

2.  Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.

Authors:  Tim Rhodes; Mark Davis; Ali Judd
Journal:  Addiction       Date:  2004-05       Impact factor: 6.526

3.  Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.

Authors:  K M Roy; S J Hutchinson; S Wadd; A Taylor; S O Cameron; S Burns; P Molyneaux; P G McIntyre; D J Goldberg
Journal:  Epidemiol Infect       Date:  2006-08-08       Impact factor: 2.451

4.  Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.

Authors:  A Judd; S Hutchinson; S Wadd; M Hickman; A Taylor; S Jones; J V Parry; S Cameron; T Rhodes; S Ahmed; S Bird; R Fox; A Renton; G V Stimson; D Goldberg
Journal:  J Viral Hepat       Date:  2005-11       Impact factor: 3.728

5.  Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

Authors:  A Taylor; D Goldberg; S Hutchinson; S Cameron; S M Gore; J McMenamin; S Green; A Pithie; R Fox
Journal:  J Infect       Date:  2000-03       Impact factor: 6.072

6.  Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.

Authors:  A J Sutton; N J Gay; W J Edmunds
Journal:  Vaccine       Date:  2005-12-09       Impact factor: 3.641

7.  HIV risk after release from prison: a qualitative study of former inmates.

Authors:  Jennifer Adams; Carolyn Nowels; Karen Corsi; Jeremy Long; John F Steiner; Ingrid A Binswanger
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

8.  Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots.

Authors:  Ali Judd; John Parry; Matthew Hickman; Tamara McDonald; Laura Jordan; Kim Lewis; Marcela Contreras; Geoff Dusheiko; Graham Foster; Noël Gill; Katie Kemp; Janice Main; Iain Murray-Lyon; Mark Nelson
Journal:  J Med Virol       Date:  2003-09       Impact factor: 2.327

Review 9.  Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature.

Authors:  K Roy; G Hay; R Andragetti; A Taylor; D Goldberg; L Wiessing
Journal:  Epidemiol Infect       Date:  2002-12       Impact factor: 2.451

10.  Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.

Authors:  A J Sutton; N J Gay; W J Edmunds; V D Hope; O N Gill; M Hickman
Journal:  BMC Infect Dis       Date:  2006-06-08       Impact factor: 3.090

View more
  2 in total

1.  Prevalence of mixed genotype hepatitis C virus infections in the UK as determined by genotype-specific PCR and deep sequencing.

Authors:  A L McNaughton; V B Sreenu; G Wilkie; R Gunson; K Templeton; E C M Leitch
Journal:  J Viral Hepat       Date:  2018-02-21       Impact factor: 3.728

2.  Hepatitis C avoidance in injection drug users: a typology of possible protective practices.

Authors:  Catherine McGowan; Magdalena Harris; Tim Rhodes
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.